Literature DB >> 30312718

Application of polydopamine in tumor targeted drug delivery system and its drug release behavior.

Zhe Wang1, Yaou Duan2, Yanwen Duan3.   

Abstract

Inspired by the bionics of marine mussels, polydopamine (PDA), a new polymer with unique physicochemical properties was discovered. Due to its simple preparation, good biocompatibility, unique drug-loading methods, PDA has attracted tremendous attentions in field of drug delivery and imaging, and the combination of chemotherapy and other therapies or diagnostic methods, such as photothermotherapy (PTT), photoacoustic imaging (PAI), magnetic resonance imaging (MRI), etc. As an excellent drug carrier in tumor targeted drug delivery system, the drug release behavior of drug-loaded PDA-based nanoparticles is also an important factor to be considered in the establishment of drug delivery systems. Therefore, the purpose of this review is to provide a comprehensive overview of the various applications of PDA in tumor targeted drug delivery systems and to gain insight into the release behavior of the drug-loaded PDA-based nanocarriers. A sufficient understanding and discussion of these aspects is expected to provide a better way to design more rational and effective PDA-based tumor nano-targeted delivery systems. Apart from this, the prospects for the future application of PDA in this field and some unique insights are listed at the end of the article.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Polydopamine; Release behavior; Tumor targeted drug delivery systems

Mesh:

Substances:

Year:  2018        PMID: 30312718     DOI: 10.1016/j.jconrel.2018.10.009

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  22 in total

1.  Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer.

Authors:  Xiang Li; Qian Zou; Jing Zhang; Peng Zhang; Xiong Zhou; Satya Siva Kishan Yalamarty; Xinli Liang; Yali Liu; Qin Zheng; Jianqing Gao
Journal:  Int J Nanomedicine       Date:  2020-09-11

2.  Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.

Authors:  Vy Anh Tran; Van Giau Vo; Kyuhwan Shim; Sang-Wha Lee; Seong Soo A An
Journal:  Int J Nanomedicine       Date:  2020-10-08

3.  A Novel Nanoparticle Preparation to Enhance the Gastric Adhesion and Bioavailability of Xanthatin.

Authors:  Yaqian Zhou; Xingyu Zhu; Shangyang Lin; Chenqi Zhu; Li Wu; Rui Chen; Zhipeng Chen; Weidong Li
Journal:  Int J Nanomedicine       Date:  2020-07-14

4.  Combined Therapeutic Effects of 131I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer.

Authors:  Pingping Wu; Huayun Zhu; Yan Zhuang; Xiaofeng Sun; Ning Gu
Journal:  Int J Nanomedicine       Date:  2020-04-23

5.  Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer.

Authors:  You-Hong You; Yu-Feng Lin; Bhanu Nirosha; Huan-Tsung Chang; Yu-Fen Huang
Journal:  Nanotheranostics       Date:  2019-06-06

Review 6.  Nanoparticles modified by polydopamine: Working as "drug" carriers.

Authors:  Anting Jin; Yitong Wang; Kaili Lin; Lingyong Jiang
Journal:  Bioact Mater       Date:  2020-04-18

7.  Polydopamine Nanosphere with In-Situ Loaded Gentamicin and Its Antimicrobial Activity.

Authors:  Rahila Batul; Mrinal Bhave; Peter J Mahon; Aimin Yu
Journal:  Molecules       Date:  2020-04-30       Impact factor: 4.411

8.  Redox-Responsive Disulfide Bond-Bridged mPEG-PBLA Prodrug Micelles for Enhanced Paclitaxel Biosafety and Antitumor Efficacy.

Authors:  Sheng Chang; Yanfei Wang; Tianyi Zhang; Xiaohui Pu; Lanlan Zong; Heyun Zhu; Luling Zhao; Bo Feng
Journal:  Front Oncol       Date:  2019-08-27       Impact factor: 6.244

Review 9.  Applications of Melanin and Melanin-Like Nanoparticles in Cancer Therapy: A Review of Recent Advances.

Authors:  Stefania Cuzzubbo; Antoine F Carpentier
Journal:  Cancers (Basel)       Date:  2021-03-23       Impact factor: 6.639

10.  Development of PDA Nanoparticles for H9N2 Avian Influenza BPP-V/BP-IV Epitope Peptide Vaccines: Immunogenicity and Delivery Efficiency Improvement.

Authors:  Yongqing Liu; Xiaoli Wang; Jiangfei Zhou; Shuaibing Shi; Tengfei Shen; Liangliang Chen; Min Zhang; Chengshui Liao; Chen Wang
Journal:  Front Immunol       Date:  2021-07-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.